- Home
- RETO vs CLDI Comparison
RETO vs CLDI Comparison
Compare RETO & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- CLDI
- Stock Information
- Founded
- RETO 1999
- CLDI 2014
- Country
- RETO China
- CLDI United States
- Employees
- RETO N/A
- CLDI N/A
- Industry
- RETO Multi-Sector Companies
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RETO Consumer Discretionary
- CLDI Health Care
- Exchange
- RETO Nasdaq
- CLDI Nasdaq
- Market Cap
- RETO 24.7M
- CLDI 20.2M
- IPO Year
- RETO 2017
- CLDI N/A
- Fundamental
- Price
- RETO $1.71
- CLDI $1.67
- Analyst Decision
- RETO
- CLDI
- Analyst Count
- RETO 0
- CLDI 0
- Target Price
- RETO N/A
- CLDI N/A
- AVG Volume (30 Days)
- RETO 15.4K
- CLDI 465.2K
- Earning Date
- RETO 10-27-2025
- CLDI 08-08-2025
- Dividend Yield
- RETO N/A
- CLDI N/A
- EPS Growth
- RETO N/A
- CLDI N/A
- EPS
- RETO N/A
- CLDI N/A
- Revenue
- RETO $1,828,976.00
- CLDI N/A
- Revenue This Year
- RETO N/A
- CLDI N/A
- Revenue Next Year
- RETO N/A
- CLDI N/A
- P/E Ratio
- RETO N/A
- CLDI N/A
- Revenue Growth
- RETO N/A
- CLDI N/A
- 52 Week Low
- RETO $1.53
- CLDI $1.54
- 52 Week High
- RETO $17.20
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- RETO 26.74
- CLDI 29.99
- Support Level
- RETO $1.82
- CLDI $1.59
- Resistance Level
- RETO $1.98
- CLDI $1.88
- Average True Range (ATR)
- RETO 0.13
- CLDI 0.46
- MACD
- RETO -0.00
- CLDI -0.18
- Stochastic Oscillator
- RETO 19.36
- CLDI 1.99
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.